2024 Jenesis Innovative Research Awards™

The Jenesis Innovative Research Awards™ provide support to US- or Canada-based investigators who are engaged in innovative research that will advance scientific knowledge and enhance patient care in pulmonary hypertension (PH), idiopathic pulmonary fibrosis (IPF), or lung transplantation. The program encourages submissions exploring topics in health equity, determinants of health, and marginalized populations. Applicants must be part of an appropriate research group and under the supervision of a qualified mentor. Three awards of up to $100,000 each will be issued annually.
The 2024 award cycle will be open for applications through Monday, April 15, 2024, 11:59 pm ET.

2024 Jenesis Trailblazer Awards™

The Jenesis TrailblazerAwards™ recognize two exceptional US- or Canada-based female researchers or clinicians who have completed innovative research in the fields of pulmonary hypertension (PH), idiopathic pulmonary fibrosis (IPF), or lung transplantation. Up to two non-monetary awards will be issued annually.

The 2024 award cycle will be open for nominations through Monday, April 15, 2024, 11:59 pm ET.

Learn more about the Trailblazer Research Awards and Scoring Criteria.

 

If you have a question, please email utjenesisawards@j-jhealth.com or call the Jenesis Research Program Coordinator at 516-287-5015.

 

© 2023 United Therapeutics Corporation. All rights reserved.